Experiments

Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).

• Mutational analysis of human CEACAM1: the potential of receptor polymorphism in increasing host susceptibility to bacterial infection.

  PMID 16953805 · PMC1859983 · Cellular microbiology · 2007 · 7 claims · 8 setups

  Full-text index only

  Ile-91 is the primary docking residue required for binding of all tested Nm and Hi strains to CEACAM1, despite structural diversity of bacterial ligands

  ceacam1 meningitidis influenzae ha3 homology site-directed receptor

• Use of proteomics for validation of the isolation process of clotting factor IX from human plasma.

  PMID 19819359 · PMC2818390 · Journal of proteomics · 2010 · 8 claims · 8 setups

  Full-text index only

  Proteomic techniques (LC-MS/MS, iTRAQ, immunochemical/biochemical methods) can monitor and validate each production step of pd F IX isolation

  plasma in-process chromatographic one-stage competitive elisa

• Proteomic characterization of plasma-derived clotting factor VIII-von Willebrand factor concentrates.

  PMID 19768705 · PMC3030255 · Electrophoresis · 2009 · 8 claims · 8 setups

  Full-text index only

  Commercial plasma-derived FVIII/VWF concentrates contain significant amounts of non-FVIII/VWF plasma proteins as impurities

  plasma-derived octanate sec fviii sds-page size-exclusion lc-esi-ms